The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces… Read More »NEWS: Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures The Hague, Netherlands, 3 October 2023: Amber Implants, an innovative medical technology company developing next-generation implants… Read More »NEWS: Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
The Hague, Netherlands, May 31, 2023: Amber Implants has achieved a significant milestone by obtaining regulatory approval for our clinical study in Europe. This remarkable achievement… Read More »News: Amber Implants receives approval for First in Human study in Europe
The Hague, Netherlands, July 6, 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces that it has… Read More »News: Amber Implants receives ISO 13485:2016 certification.
Today is an exciting day for Amber Implants! We are proud to announce that our product, the VCFix® Spinal System, has successfully passed all preclinical… Read More »News: VCFix® Spinal system has passed all the preclinical tests required for clinical use of the device
The Hague, Netherlands, 19 January 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the successful… Read More »NEWS: Amber Implants Closes US$10 M Series A Financing